KRAS and colorectal carcinoma: Since all of the patients carried KRAS mutations, our results are in accordance with a recent report [41] showing that CRC cell lines harbouring KRAS mutations in codon 13 are characterised by a significant upregulation of several genes involved in ribosome genesis, metabolism, and mRNA translation paralleled by increased proliferation and protein synthesis.